Komori
Kissei Pharmaceutical (4547) · InitiativeRestated

Advisory Body Ensuring Board Independence and Transparency

First written in FY2016. 4 of 5 entries say "Restated". Latest entry: FY2024.

5entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20242016: 120162017: 120172018: 120182019: 120192020: 020202021: 020212022: 020222023: 020232024: 12024
Same theme, other companies
Operation of the Nomination and Compensation Committee Centered on Independent Outside DirectorsA theme 192 companies write about · 0 as a headwind · 192 as a tailwind

The whole theme swung hardest in 2025: 9 of 89 companies on the "Worse" side.

87 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「We have established a Nomination and Compensation Deliberation Committee as an advisory body to the Board of Directors. It deliberates on proposals for the appointment and dismissal of officers and nominees, director compensation levels and other matters, and makes proposals to the Board of Directors.」

    The company has reconfirmed the mechanism for ensuring the independence, objectivity and transparency of Board of Directors deliberations through the Nomination and Compensation Deliberation Committee.
  2. FY2019RestatedAnnual report

    「To ensure the independence and objectivity of Board of Directors deliberations and the transparency of the process, we have established a Nomination and Compensation Deliberation Committee as an advisory body to the Board of Directors.」

    The company has reconfirmed its structure for ensuring the independence, objectivity and transparency of the Board of Directors through the Nomination and Compensation Deliberation Committee.
  3. FY2018RestatedAnnual report

    「To ensure the independence and objectivity of Board of Directors deliberations and the transparency of the process, we have established a Nomination and Compensation Deliberation Committee as an advisory body to the Board of Directors. The committee deliberates on nominees for directors and corporate auditors and on director compensation and other matters.」

    The company has reconfirmed its structure for ensuring the independence, objectivity and transparency of Board of Directors deliberations through the Nomination and Compensation Deliberation Committee.
  4. FY2017RestatedAnnual report

    「To ensure the independence and objectivity of Board of Directors deliberations and the transparency of the process, we have established a Nomination and Compensation Deliberation Committee as an advisory body to the Board of Directors. The committee deliberates on nominees for directors and corporate auditors and on director compensation and other matters.」

    The company has reconfirmed its structure for ensuring the independence, objectivity and transparency of Board of Directors deliberations through the Nomination and Compensation Deliberation Committee.
  5. FY2016First statedAnnual report

    「To ensure the independence and objectivity of Board of Directors deliberations and the transparency of the process, we have established a Nomination and Compensation Deliberation Committee as an advisory body to the Board of Directors. The committee deliberates on nominees for directors and corporate auditors and on director compensation and other matters.」

    The structure includes 2 outside directors and 2 outside corporate auditors, who have been reported as independent officers.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kissei Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.